TipRanks
Advertisement
Advertisement

SRZN Stock Latest News

Surrozen Initiated with Buy as IND Clearance, New Capital and External Wnt Validation Strengthen Clinical Momentum
RatingsSurrozen Initiated with Buy as IND Clearance, New Capital and External Wnt Validation Strengthen Clinical Momentum
14d ago
SRZN
Surrozen Wins FDA IND Clearance for SZN-8141 Program
PremiumCompany Announcements
Surrozen Wins FDA IND Clearance for SZN-8141 Program
14d ago
8K
SRZN
Surrozen announces FDA clearance of IND application for SZN-8141
PremiumThe Fly
Surrozen announces FDA clearance of IND application for SZN-8141
14d ago
SRZN
Surrozen price target raised to $54 from $44 at H.C. Wainwright
PremiumThe Fly
Surrozen price target raised to $54 from $44 at H.C. Wainwright
21d ago
SRZN
Two new option listings and eight option delistings on September 21st
PremiumThe Fly
Two new option listings and eight option delistings on September 21st
25d ago
COOK
FLZH
Surrozen submits investigational new drug application for SZN-8141
PremiumThe FlySurrozen submits investigational new drug application for SZN-8141
1M ago
SRZN
Surrozen initiated with an Outperform at William Blair
Premium
The Fly
Surrozen initiated with an Outperform at William Blair
2M ago
SRZN
Analyst Maintains Buy on Surrozen, Reiterates $46 Price Target on Novel Wnt Pathway Strategy in Retinal Disease
Premium
Ratings
Analyst Maintains Buy on Surrozen, Reiterates $46 Price Target on Novel Wnt Pathway Strategy in Retinal Disease
2M ago
SRZN
Surrozen: Buy Rating Reiterated as Clinical Roadmap Clarifies and IP Strengthens; Price Target Maintained at $44
PremiumRatings
Surrozen: Buy Rating Reiterated as Clinical Roadmap Clarifies and IP Strengthens; Price Target Maintained at $44
2M ago
SRZN
Patrick Dolezal Reiterates Buy on Surrozen, Keeps Price Target Unchanged at $44 Ahead of Key BRUNELLO Readout
PremiumRatings
Patrick Dolezal Reiterates Buy on Surrozen, Keeps Price Target Unchanged at $44 Ahead of Key BRUNELLO Readout
3M ago
SRZN
Surrozen Shareholders Support Board, Auditor and Pay Policies
PremiumCompany Announcements
Surrozen Shareholders Support Board, Auditor and Pay Policies
5M ago
8K
SRZN
Surrozen price target raised to $44 from $36 at H.C. Wainwright
PremiumThe Fly
Surrozen price target raised to $44 from $36 at H.C. Wainwright
5M ago
SRZN
Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
PremiumRatingsSurrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
5M ago
SRZN
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
Premium
The Fly
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
5M ago
SRZN
Surrozen management to meet with Cantor
Premium
The Fly
Surrozen management to meet with Cantor
6M ago
SRZN
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
PremiumRatings
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
6M ago
SRZN
Surrozen initiated with a Buy at TD Cowen
PremiumThe Fly
Surrozen initiated with a Buy at TD Cowen
6M ago
SRZN
Surrozen price target raised to $36 from $32 at H.C. Wainwright
PremiumThe Fly
Surrozen price target raised to $36 from $32 at H.C. Wainwright
7M ago
SRZN
Surrozen files $200M mixed securities shelf
PremiumThe Fly
Surrozen files $200M mixed securities shelf
7M ago
SRZN
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
PremiumPre-EarningsSurrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
7M ago
SRZN
Surrozen initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Surrozen initiated with an Overweight at Cantor Fitzgerald
8M ago
SRZN
Surrozen announces routine board resignation with no disputes
Premium
Company Announcements
Surrozen announces routine board resignation with no disputes
9M ago
8K
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >